DOSEHUB Trademark

Trademark Overview

On Thursday, February 8, 2018, a trademark application was filed for DOSEHUB with the United States Patent and Trademark Office. The USPTO has given the DOSEHUB trademark a serial number of 87790640. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 6, 2021. This trademark is owned by Amgen Inc.. The DOSEHUB trademark is filed in the Medical Instrument Products category with the following description:

drug delivery systems
dosehub

General Information

Serial Number87790640
Word MarkDOSEHUB
Filing DateThursday, February 8, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 6, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2018

Trademark Statements

Goods and Servicesdrug delivery systems
Pseudo MarkDOSE HUB

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 16, 2018
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Tuesday, September 7, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 6, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 6, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 8, 2021EXTENSION 5 GRANTED
Friday, December 18, 2020EXTENSION 5 FILED
Friday, January 8, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 18, 2020TEAS EXTENSION RECEIVED
Wednesday, July 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 13, 2020EXTENSION 4 GRANTED
Monday, July 13, 2020EXTENSION 4 FILED
Monday, July 13, 2020TEAS EXTENSION RECEIVED
Saturday, November 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2019EXTENSION 3 GRANTED
Thursday, October 31, 2019EXTENSION 3 FILED
Thursday, October 31, 2019TEAS EXTENSION RECEIVED
Tuesday, May 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 24, 2019EXTENSION 2 GRANTED
Friday, May 24, 2019EXTENSION 2 FILED
Friday, May 24, 2019TEAS EXTENSION RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 11, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 11, 2018EXTENSION 1 GRANTED
Tuesday, December 11, 2018EXTENSION 1 FILED
Tuesday, December 11, 2018TEAS EXTENSION RECEIVED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 31, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 5, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 5, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 16, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 27, 2018ASSIGNED TO EXAMINER
Friday, February 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 12, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

dosehub systems delivery drug